HIV PrEP Priming of Immune Effectors
NCT02593409
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
220
Enrollment
OTHER
Sponsor class
Conditions
HIV-1 Infections
Interventions
DRUG:
TDF/FTC
Sponsor
MRC/UVRI and LSHTM Uganda Research Unit